|Outcomes at mean 4.1 years||HRT||Placebo||RRI (95% CI)||NNH (CI)|
|†Abbreviations defined in glossary; RRI, NNH, and CI calculated from data in article.|
|Any venous thromboembolic event||2.5%||0.9%||162% (40 to 390)||66 (39 to 172)|
|Deep venous thrombosis||1.8%||0.7%||178% (33 to 484)||86 (48 to 279)|
|Non-idiopathic venous thromboembolic event||1.8%||0.7%||151% (23 to 412)||92 (50 to 372)|
|Pulmonary embolism||0.8%||0.3%||176% (−7 to 718)||Not significant|
|Idiopathic venous thromboembolic event||0.7%||0.2%||201% (−12 to 925)||Not significant|
Oestrogen plus progestin increased venous thromboembolic disease in postmenopausal women with coronary artery disease
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>
EBN Journal Chat
The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries
from Evidence Based Nursing (EBN).
How to participate >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.